2-Propenamide, N-[2-[[3-(3,5-dimethoxybenzoyl)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-5-(4-morpholinyl)phenyl]- manufacturers
- FGFR4-IN-11
-
- $2500.00
-
2026-07-27
- CAS:2396664-85-8
- Purity:
- Supply Ability: 10g
|
| | 2-Propenamide, N-[2-[[3-(3,5-dimethoxybenzoyl)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-5-(4-morpholinyl)phenyl]- Basic information |
| | 2-Propenamide, N-[2-[[3-(3,5-dimethoxybenzoyl)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-5-(4-morpholinyl)phenyl]- Chemical Properties |
| density | 1.334±0.06 g/cm3(Predicted) | | pka | 12.49±0.40(Predicted) |
| | 2-Propenamide, N-[2-[[3-(3,5-dimethoxybenzoyl)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-5-(4-morpholinyl)phenyl]- Usage And Synthesis |
| Uses | FGFR4-IN-11 (Compound 30) is a potent, selective, covalent FGFR4 inhibitor with an IC50 of 2.1 nM. FGFR4-IN-11 significantly inhibits the FGF19/FGFR4 signaling pathway and shows antitumor activity[1]. | | IC 50 | FGFR4: 2.1 nM (IC50) | | References | [1] Zhong Z, et al. Discovery of Novel 7-Azaindole Derivatives as Selective Covalent Fibroblast Growth Factor Receptor 4 Inhibitors for the Treatment of Hepatocellular Carcinoma. J Med Chem. 2022 May 26;65(10):7278-7295. DOI:10.1021/acs.jmedchem.2c00255 |
| | 2-Propenamide, N-[2-[[3-(3,5-dimethoxybenzoyl)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-5-(4-morpholinyl)phenyl]- Preparation Products And Raw materials |
|